The EFSUMB Guidelines on the Non-Hepatic Clinical Applications of Contrast Enhanced Ultrasound (CEUS): a New Dawn for the Escalating Use of This Ubiquitous Technique

References

• 1 Piscaglia F, Nolsoe C, Dietrich C et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS). Update 2011 on non-hepatic applications.  Ultraschall in Med. 2012;  33 33-59
• 2 Albrecht T, Blomley M JK, Bolondi L et al. Guidelines for the use of contrast agents in ultrasound. January 2004.  Ultraschall in Med. 2004;  25 249-256
• 3 Claudon M, Cosgrove D, Albrecht T et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008.  Ultraschall in Med. 2008;  29 28-44
• 4 Stang A et al. Incidentally Detected Splenic Lesions in Ultrasound: Does Contrast-Enhanced Ultrasonography Improve the Differentiation of Benign Hemangioma/Hamartoma from Malignant Lesions?.  Ultraschall in Med. 2011;  32 582-592
• 5 Hocke M, Dietrich C F. New Technology – Combined Use of 3D Contrast Enhanced Endoscopic Ultrasound Techniques.  Ultraschall in Med. 2011;  32 317-318
• 6 Girlich C et al. Comparison between Preoperative Quantitative Assessment of Bowel Wall Vascularization by Contrast-Enhanced Ultrasound and Operative Macroscopic Findings and Results of Histopathological Scoring in Crohn’s Disease.  Ultraschall in Med. 2011;  32 154-159
• 7 Heinzmann A et al. Endocavitary Contrast Enhanced Ultrasound (CEUS) – Work in Progress.  Ultraschall in Med. 2011;  DOI: 10.1055 /s-0031 – 1 299 056
• 8 Stenberg B et al. A New Technique for Assessing Renal Transplant Perfusion Preoperatively Using Contrast-Enhanced Ultrasound (CEUS) and Three-Dimensional Ultrasound (3DUS) – A Porcine Model Pilot Study.  Ultraschall in Med. 2011;  32 E8-E13
• 9 Goertz R S et al. Mesenteric Transit Time Using Contrast-Enhanced Ultrasound (CEUS) Does Not Correlate with Disease Activity in Crohn’s Disease.  Ultraschall in Med. 2011;  DOI: 10.1055 /s-0031-1 282 064
• 10 Ohrdorf S et al. Contrast-Enhanced Ultrasonography is More Sensitive Than Grayscale and Power Doppler Ultrasonography Compared to MRI in Therapy Monitoring of Rheumatoid Arthritis Patients.  Ultraschall in Med. 2011;  32 E38-E44
• 11 Klauser A et al. Contrast-Enhanced Ultrasonography for the Detection of Joint Vascularity in Arthritis – Subjective Grading Versus Computer-Aided Objective Quantification.  Ultraschall in Med. 2011;  32 E31-E37
• 12 Linde H N et al. Contrast-Enhancend Sonography (CEUS) in Pneumonia: Typical Patterns and Clinical Value – a Retrospective Study on n = 50 Patients.  Ultraschall in Med. 2011;  DOI: 10.1055 /s-0031-1 273 280
• 13 Dormagen J et al. Contrast-Enhanced Ultrasound of the Injured Spleen After Embolization – Comparison with Computed Tomography.  Ultraschall in Med. 2011;  32 485-491
• 14 Mostbeck G. CEUS of Adrenal Mass Lesions - the Break-Through?.  Ultraschall in Med. 2011;  32 437-439
• 15 Piscaglia F, Bolondi L. The safety of SonoVue in abdominal applications: retrospective analysis of 23 188 investigations.  Ultrasound in Med Biol. 2006;  32 1369-1375
• 16 Piskunowicz M et al. Intravenous Application of Second-Generation Ultrasound Contrast Agents in Children: A Review of the Literature.  Ultraschall in Med. 2011;  DOI: 10.1055 /s-0031-1281 936
• 17 General Medical Council United Kingdom .Good practice in prescribing medicines – guidance for doctors September 2008. http://www.gmc-uk.org/guidance/ethical_guidance/prescriptions_faqs.asp#10 (website accessed December 2011)
• 18 The use of unlicensed medicines or licensed medicines for unlicensed applications in paediatric practice. Policy statement produced by the joint RCPCH/NPPG Standing Committee on Medicines http://www.rcpch.ac.uk/medicines#Unlicensed_medicines_statement – Statement on unlicensed medicines (October 2010) (website accessed December 2011)